270 related articles for article (PubMed ID: 22235061)
21. Ifosfamide-induced Encephalopathy With Rapid Response to Thiamine: A Pediatric Case.
Müngen E; Yaman Bajin İ; Öz S; Günbey C; Anlar B; Aydin B
J Pediatr Hematol Oncol; 2022 Oct; 44(7):402-404. PubMed ID: 35536996
[TBL] [Abstract][Full Text] [Related]
22. Ifosfamide induced encephalopathy in a child with osteosarcoma.
Sarbay H; Demir ÜF; Yılmaz G; Atay AA; Malbora B
J Oncol Pharm Pract; 2021 Jul; 27(5):1302-1306. PubMed ID: 33023384
[TBL] [Abstract][Full Text] [Related]
23. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.
Sweiss KI; Beri R; Shord SS
Drug Saf; 2008; 31(11):989-96. PubMed ID: 18840018
[TBL] [Abstract][Full Text] [Related]
24. Ifosfamide - History, efficacy, toxicity and encephalopathy.
Idle JR; Beyoğlu D
Pharmacol Ther; 2023 Mar; 243():108366. PubMed ID: 36842616
[TBL] [Abstract][Full Text] [Related]
25. Ifosfamide-induced encephalopathy in patients with uterine sarcoma.
Liu YL; Tsai SH; Chang FW; Yu MH
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):77-80. PubMed ID: 20466298
[TBL] [Abstract][Full Text] [Related]
26. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
27. CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.
Gillman PK
J Psychopharmacol; 2011 Mar; 25(3):429-36. PubMed ID: 20142303
[TBL] [Abstract][Full Text] [Related]
28. Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
Cherry MA; Bhardwaj H; Hopps S; Srour S; Pant S
J Oncol Pharm Pract; 2013 Sep; 19(3):261-4. PubMed ID: 23135805
[TBL] [Abstract][Full Text] [Related]
29. Cerebral formation in situ of S-carboxymethylcysteine after ifosfamide administration to mice: a further clue to the mechanism of ifosfamide encephalopathy.
Lerch S; Küpfer A; Idle JR; Lauterburg BH
Toxicol Lett; 2006 Mar; 161(3):188-94. PubMed ID: 16229978
[TBL] [Abstract][Full Text] [Related]
30. Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Gharaibeh EZ; Telfah M; Powers BC; Salacz ME
J Oncol Pharm Pract; 2019 Oct; 25(7):1784-1786. PubMed ID: 30348070
[TBL] [Abstract][Full Text] [Related]
31. A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature.
Chain G; Kalia M; Kestenbaum K; Pappas L; Sechser-Perl A; Campino GA; Zaghloul N
BMC Pediatr; 2022 Feb; 22(1):76. PubMed ID: 35109795
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity.
Richards A; Marshall H; McQuary A
J Oncol Pharm Pract; 2011 Dec; 17(4):372-80. PubMed ID: 20861178
[TBL] [Abstract][Full Text] [Related]
33. Ifosfamide encephalopathy: a case report.
Pavarana M; Nortilli R; Valcamonico F; Romito S; Zanoni T; Cetto G
Tumori; 2005; 91(2):197-200. PubMed ID: 15948552
[TBL] [Abstract][Full Text] [Related]
34. Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.
Turner AR; Duong CD; Good DJ
Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):435-9. PubMed ID: 14570094
[TBL] [Abstract][Full Text] [Related]
35. An easily overlooked cause of toxic encephalopathy: methylene blue in a patient on an SSRI.
Honoré PJ; Deianova N; Loret G; Hemelsoet D
Acta Neurol Belg; 2018 Mar; 118(1):121-122. PubMed ID: 28748330
[No Abstract] [Full Text] [Related]
36. Evaluating risk factors for the development of ifosfamide encephalopathy.
David KA; Picus J
Am J Clin Oncol; 2005 Jun; 28(3):277-80. PubMed ID: 15923801
[TBL] [Abstract][Full Text] [Related]
37. Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Duflot T; Marie-Cardine A; Verstuyft C; Filhon B; Pereira T; Massy-Guillemant N; Joannidès R; Bellien J; Lamoureux F
Fundam Clin Pharmacol; 2018 Jun; 32(3):337-342. PubMed ID: 29319893
[TBL] [Abstract][Full Text] [Related]
38. Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy.
Rowley M; Riutort K; Shapiro D; Casler J; Festic E; Freeman WD
Neurocrit Care; 2009; 11(1):88-93. PubMed ID: 19263250
[TBL] [Abstract][Full Text] [Related]
39. Ifosfamide encephalopathy and use of methylene blue. A case report of different sequential neurotoxicity.
Giovanis P; Garna A; Marcante M; Nardi K; Giusto M
Tumori; 2009; 95(4):545-6. PubMed ID: 19856674
[TBL] [Abstract][Full Text] [Related]
40. Patient Safety and Methylene Blue-Associated Severe Serotonin Toxicity.
Rosenbaum HK; Gillman PK
A A Case Rep; 2016 Jul; 7(1):1. PubMed ID: 27415030
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
